Serum Proteome Profiles in Stricturing Crohn’s Disease: A Pilot Study, 19 May 2015, Crohn’s & Colitis Foundation of America, Inc, Townsend, Peter MD; Zhang, Qibin PhD; Shapiro, Jason MD; Webb-Robertson, Bobbie-Jo PhD; Bramer, Lisa PhD; Schepmoes, Athena A. BS; Weitz, Karl K. BS; Mallette, Meaghan BS, MS; Moniz, Heather BS; Bright, Renee MS; Kamphaus, Tania PhD; Shah, Samir A. MD; Sands, Bruce E. MD, MS; Leleiko, Neal MD, PhD
Background: Crohn’s disease (CD) is a form of inflammatory bowel disease with different described behaviors, including stricture. At present, there are no laboratory studies that can differentiate stricturing CD from other phenotypes of inflammatory bowel disease. We performed a pilot study to examine differences in the proteome among patients with stricturing CD, nonstricturing CD, and ulcerative colitis.
Methods: Serum samples were selected from the Ocean State Crohn’s and Colitis Area Registry, an established cohort of patients with inflammatory bowel disease. Patients with CD with surgically resected stricture were matched with similar patients with CD without known stricture and with ulcerative colitis. Serum samples from each patient were digested and analyzed using liquid chromatography-mass spectrometry to characterize the proteome. Statistical analyses were performed to identify peptides and proteins that can differentiate CD with stricture.
Results: Samples from 9 patients in each group (27 total patients) were analyzed. Baseline demographic characteristics were similar among the 3 groups. We quantified 7668 peptides and 897 proteins for analysis. Receiver operating characteristic analysis identified a subset of peptides with an area under the curve greater than 0.9, indicating greater separation potential. Partial least squares discriminant analysis was able to distinguish among the three groups with up to 70% accuracy by peptides and up to 80% accuracy by proteins. We identified the significantly different proteins and peptides and determined their function based on previously published literature.
Conclusions: The serum of patients with stricturing CD, nonstricturing CD, and ulcerative colitis is distinguishable through proteomic analysis. Some of the proteins that differentiate the stricturing phenotype have been implicated in complement activation, fibrinolytic pathways, and lymphocyte adhesion.